Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06167369
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2023-11-23
Brief Title:
Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients
Sponsor:
Technische Universität Dresden
Organization:
Technische Universität Dresden
Study Overview
Official Title:
Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to investigate biomarkers and neurocognitive markers of neurodegenerative processes in obstructive sleep apnea patients
The main questions the study aims to answer are
Does neurodegeneration assessed by neurobiological markers and neurocognitive test performance exists in obstructive sleep apnea
Are these neurodegenerative markers are associated with the adherence to clinical prescribed positive airway pressure therapy
Newly diagnosed patients with obstructive sleep apnea will be observed during the use of clinical prescribed positive pressure therapy Different study related investigations take place before and six months after treatment start
Researchers will compare after six months the group of adherent treatment participants with the non-adherent treatment participants group to investigate if differences in the observed neurobiological or neurocognitive parameters exist
The main questions the study aims to answer are
Does neurodegeneration assessed by neurobiological markers and neurocognitive test performance exists in obstructive sleep apnea
Are these neurodegenerative markers are associated with the adherence to clinical prescribed positive airway pressure therapy
Newly diagnosed patients with obstructive sleep apnea will be observed during the use of clinical prescribed positive pressure therapy Different study related investigations take place before and six months after treatment start
Researchers will compare after six months the group of adherent treatment participants with the non-adherent treatment participants group to investigate if differences in the observed neurobiological or neurocognitive parameters exist
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None